These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 22563194

  • 1. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M, Piche T, Ducrotte P, Lunaud B, Cardot JM, Bernalier-Donadille A.
    World J Gastroenterol; 2012 May 07; 18(17):2067-75. PubMed ID: 22563194
    [Abstract] [Full Text] [Related]

  • 2. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R and Lactobacillus rhamnosus CLR2 improve quality-of-life and IBS symptoms: a double-blind, randomised, placebo-controlled study.
    Preston K, Krumian R, Hattner J, de Montigny D, Stewart M, Gaddam S.
    Benef Microbes; 2018 Sep 18; 9(5):697-706. PubMed ID: 29888656
    [Abstract] [Full Text] [Related]

  • 3. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L.
    World J Gastroenterol; 2016 Dec 28; 22(48):10631-10642. PubMed ID: 28082816
    [Abstract] [Full Text] [Related]

  • 4. Lactobacillus casei rhamnosus Lcr35 in the Management of Functional Constipation in Children: A Randomized Trial.
    Wojtyniak K, Horvath A, Dziechciarz P, Szajewska H.
    J Pediatr; 2017 May 28; 184():101-105.e1. PubMed ID: 28284477
    [Abstract] [Full Text] [Related]

  • 5. Partially hydrolyzed guar gum in pediatric functional abdominal pain.
    Romano C, Comito D, Famiani A, Calamarà S, Loddo I.
    World J Gastroenterol; 2013 Jan 14; 19(2):235-40. PubMed ID: 23345946
    [Abstract] [Full Text] [Related]

  • 6. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
    Lorenzo-Zúñiga V, Llop E, Suárez C, Alvarez B, Abreu L, Espadaler J, Serra J.
    World J Gastroenterol; 2014 Jul 14; 20(26):8709-16. PubMed ID: 25024629
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and dose response of Lactiplantibacillus plantarum in diarrhea-predominant irritable bowel syndrome.
    Martoni CJ, Srivastava S, Damholt A, Leyer GJ.
    World J Gastroenterol; 2023 Jul 28; 29(28):4451-4465. PubMed ID: 37576702
    [Abstract] [Full Text] [Related]

  • 8. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
    Pedersen N, Andersen NN, Végh Z, Jensen L, Ankersen DV, Felding M, Simonsen MH, Burisch J, Munkholm P.
    World J Gastroenterol; 2014 Nov 21; 20(43):16215-26. PubMed ID: 25473176
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
    Anderle K, Wolzt M, Moser G, Keip B, Peter J, Meisslitzer C, Gouya G, Freissmuth M, Tschegg C.
    World J Gastroenterol; 2022 Dec 14; 28(46):6573-6588. PubMed ID: 36569277
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.
    Kwon H, Nam EH, Kim H, Jo H, Bang WY, Lee M, Shin H, Kim D, Kim J, Kim H, Lee J, Jung YH, Yang J, Won DD, Shin M.
    Sci Rep; 2024 Sep 27; 14(1):22384. PubMed ID: 39333245
    [Abstract] [Full Text] [Related]

  • 14. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.
    Martoni CJ, Srivastava S, Leyer GJ.
    Nutrients; 2020 Jan 30; 12(2):. PubMed ID: 32019158
    [Abstract] [Full Text] [Related]

  • 15. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 16. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG.
    J Gastroenterol Hepatol; 2014 Jan 15; 29(1):52-9. PubMed ID: 23829297
    [Abstract] [Full Text] [Related]

  • 17. Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.
    Chmielewska-Wilkoń D, Reggiardo G, Egan CG.
    World J Gastroenterol; 2014 Sep 14; 20(34):12283-91. PubMed ID: 25232263
    [Abstract] [Full Text] [Related]

  • 18. Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial.
    Di Nardo G, Bernardo L, Cremon C, Barbara G, Felici E, Evangelisti M, Ferretti A, Furio S, Piccirillo M, Coluzzi F, Parisi P, Mauro A, Di Mari C, D'Angelo F, Mennini M.
    Nutrition; 2024 Jun 14; 122():112397. PubMed ID: 38479039
    [Abstract] [Full Text] [Related]

  • 19. Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.
    Mourey F, Decherf A, Jeanne JF, Clément-Ziza M, Grisoni ML, Machuron F, Legrain-Raspaud S, Bourreille A, Desreumaux P.
    World J Gastroenterol; 2022 Jun 14; 28(22):2509-2522. PubMed ID: 35979259
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.